-
Tel
- Tel+65 89686988
-
E-mail
- E-mailmarketing@cytoniche.com
- TOP
Accelerating the Future of Cell & Gene Therapy
At CytoNiche, we specialize in simplifying the complex world of CGT, especially mesenchymal stem/stromal cells (MSCs) to drive the success of therapeutic commercialization.
Our solutions empower you to scale up production with cost-effective, high-quality cells, so that you can focus on what you do best —— developing transformative therapeutics. By optimizing access and affordability, we accelerate the timeline for bringing groundbreaking products to market.
We Offer
News & Events
Jul 23,2025
Singapore | July 21, 2025 — CytoNiche Biotech celebrated the grand opening of its 3D FloTrix™ Experience Hub in Singapore, marking a pivotal step in globalizing its breakthrough 3D cell manufacturing platform—the technology behind China’s first approved stem cell drug, priced at just 1/70th the cost of comparable therapies (e.g., $194,000/dose in the U.S. vs. ~$2,700/dose in China).
Igniting a new era in industrial cell development
3D FloTrix™ Experience Hub
Synapse #06-11, 3 Biopolis Drive, Singapore 138623
CytoNiche, FloTrix, TableTrix, RecomTrix, Architect for Cells and the microcarrier icon are trademarks of CytoNiche Biotech.
Copyright © 2025 CytoNiche Biotech Pte Ltd.